Skip to Main Content

File this under “How ironic!”

Last week, the Drug Enforcement Agency took a significant step that will make it easier for Insys Therapeutics to market its synthetic marijuana, which won regulatory approval last year to treat weight loss in AIDS patients and nausea caused by chemotherapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!